Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2833352
Author(s) Waschbisch, A; Atiya, M; Schaub, C; Derfuss, T; Schwab, S; Lee, D H; Müller, M; Linker, R A
Author(s) at UniBasel Derfuss, Tobias Johannes
Year 2013
Title Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity
Journal Journal of the neurological sciences
Volume 331
Number 1-2
Pages / Article-Number 72-5
Keywords Optic neuritis, RION, CRION, Neuromyelitis-optica, Multiple sclerosis, Inflammatory neuropathy
Abstract Recurrent optic neuritis is frequently observed in multiple sclerosis (MS) and is a typical finding in neuromyelitis optica (NMO). Patients that lack further evidence of demyelinating disease are diagnosed with RION (recurrent isolated optic neuritis) or CRION (chronic relapsing inflammatory neuropathy) if they require immunosuppressive therapy to prevent further relapses. The etiology and disease course of this rare condition are not well defined. We studied a series of 10 patients who presented with recurrent episodes of isolated optic neuritis (ON, n=57) and were followed over a median of 3.5 years. Visual acuity was severely reduced at the nadir of the disease (20/200 to 20/800). All patients had MRI non-diagnostic for MS/NMO and were aquaporin-4 antibody negative. Six patients fulfilled the CRION criteria. In two of these a single ON followed by a long disease-free interval preceded development of CRION for years, suggesting the conversion of an initially "benign" isolated ON into the chronic relapsing course. Cerebrospinal fluid (CSF) analysis revealed mild pleocytosis in 5 patients, identical oligoclonal bands in serum and CSF were observed in 2 patients, while the others remained negative. In conclusion, recurrent ON is a disease entity that requires aggressive glucocorticoid and eventually long-term immunosuppressive therapy to prevent substantial visual impairment.
Publisher Elsevier
ISSN/ISBN 0022-510X
edoc-URL http://edoc.unibas.ch/dok/A6338648
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.jns.2013.05.012
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/23735776
ISI-Number WOS:000322415000014
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.352 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024